Connection
Mandy Sakamoto to Mutation
This is a "connection" page, showing publications Mandy Sakamoto has written about Mutation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.204 |
|
|
|
-
Patil T, Gao D, Watson A, Sakamoto M, Nie Y, Gibson A, Dean ML, Yoder BA, Miller E, Stalker M, Aisner DL, Bunn PA, Schenk EL, Marmarelis ME, Bennati C, Navani V, Zhang Y, Camidge DR. The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations. Lung Cancer. 2025 01; 199:108040.
Score: 0.098
-
Sakamoto M, Patil T. MET alterations in advanced non-small cell lung cancer. Lung Cancer. 2023 04; 178:254-268.
Score: 0.087
-
Azelby CM, Sakamoto MR, Bowles DW. ROS1 Targeted Therapies: Current Status. Curr Oncol Rep. 2021 06 14; 23(8):94.
Score: 0.019